NICE (Multiple) Technology Appraisal Guidance No 156 – Routine
antenatal anti-D prophylaxis for women who are rhesus D negative
(Review of NICE technology appraisal guidance 41)
Web reference for appraisal and other related
documents: http://www.nice.org.uk/guidance/TA156
NHSScotland should note that:
1. No important differences were identified for the NICE
appraisal no. 156 relating to routine antenatal anti-D
prophylaxis and NHS Quality Improvement
Scotland advises that the recommendations are as valid for Scotland
as for England and Wales.
2. NHSScotland should take account of the NICE appraisal no. 156
and this NHS Quality Improvement Scotland email in its planning,
funding and provision of services to ensure that recommended drugs
or treatments are made available to meet clinical need.
3. NHS Quality Improvement Scotland advice represents the
evidence-based view of NHS Quality Improvement Scotland.
4. This advice does not override or replace the individual
responsibility of health professionals to make appropriate
decisions in the circumstances of their individual patients, in
consultation with the patient and/or guardian or carer.
5. No other publications on the NICE appraisal no. 156 will be
issued by NHS Quality Improvement Scotland.
6. Copies of the NICE appraisals can be downloaded from
http://www.nice.org.uk/. Also on the
website are tools (a costing template and audit criteria) that NICE
has developed to help organisations to implement appraisals.
Finally, an easy to read summary of the appraisal, called
"understanding NICE guidance" is published on the NICE website to
provide information for patients and the public.
8. Hard copies of the NICE appraisals are available from NHS
Quality Improvement Scotland (contact Shonagh Buchanan, tel 0141
225 6993 or email shonagh.buchanan@nhs.net) and all NICE appraisals
and NHS Quality Improvement Scotland advice are available on the
NHS Quality Improvement Scotland website (http://www.nhshealthquality.org/)
Published Date: 27 August 2008
